TuesdaySep 27, 2022 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Providing Quantum Applications for Life Sciences Industry With Potential to Transform Discovery, Production, and More

Quantum computing provides companies with promising new technologies that have the potential to streamline the drug development and patient trial processes, potentially finding greater efficiencies than classical computing systems D-Wave has demonstrated that annealing quantum computers could play a transformational role in the life sciences industry, as illustrated by the company’s work with Menten AI and its achievements in protein design The life sciences industry is centered around researching, developing, and manufacturing products to improve the lives of humans – including drug discovery. Drug discovery is a high-risk, high-reward field that helps to deliver life-changing clinical benefits to millions of…

Continue Reading

FridaySep 16, 2022 9:00 am

Research from D-Wave Quantum Inc. (NYSE: QBTS) Demonstrates Large-Scale Coherent Quantum Annealing

D-Wave has announced first ever demonstration of large-scale coherence in quantum annealers New research findings open the door to simulations of exotic phases of matter (unusual states of matter, outside of liquid, solid or gas, that make up the universe)  The company is further exploring the potential of annealing quantum computing for future products, services, and software applications D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, is focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials science, drug discovery, scheduling, fault detection, and financial modeling, and is…

Continue Reading

Contact us: (310) 299-1717